文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

省小钱,花大钱:减少麻疹预防支持的成本代价

Penny wise, pound foolish: The cost of reduced support for measles prevention.
PubMed 文献 · Vaccine · 2025-10-03

本文分析美国2025年可能发生的1500例麻疹暴发的经济负担,纳入直接医疗成本、生产力损失和公共卫生应对支出。

要点

  • 2025年美国已报告超过1400例麻疹病例,该病此前已被宣布消除。

核心结论

  • 这些估计凸显了疫苗接种覆盖率下降和联邦对免疫规划支持减少的财政影响。
  • 尽管当前疫苗基础设施可能显得昂贵,但可预防暴发的潜在下游经济负担超过初始项目投资。

研究设计与样本

  • 本文为经济学分析,估算2025年潜在1500例麻疹暴发的经济负担,纳入直接医疗成本、生产力损失和公共卫生应对支出。

主要发现

  • 2025年已报告超过1400例麻疹病例。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Measles, a vaccine-preventable disease previously declared eliminated in the United States, is reemerging with over 1400 cases reported in 2025. This analysis estimates the economic burden of a potential 1500-case outbreak in 2025, incorporating direct medical costs, productivity losses, and public health response expenditures. At base-case assumptions, the 2025 outbreak could cost $90.0 million, or $59,996 per case. Sensitivity analyses indicated total costs could range from approximately $16 million in a best-case scenario to $199 million in a worst-case scenario, depending on hospitalization rates, productivity loss assumptions, and public health response costs. These estimates underscore the fiscal implications of reduced vaccination coverage and diminishing federal support for immunization programs. While the current vaccine infrastructure may appear costly, the potential downstream economic burden of preventable outbreaks outweighs the initial program investment.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Mattingly TJ. Penny wise, pound foolish: The cost of reduced support for measles prevention. Vaccine. 2025. PMID: 41045634. doi:10.1016/j.vaccine.2025.127830

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。